Literature DB >> 6207524

[Reversible paraplegia following intrathecal injection of high doses of human gammaglobulins in the treatment of low-grade tetanus. 4 cases].

R Robert, J Rouffineau, A Cremault, J L Bauple, O Pourrat, R Gil, D Patte.   

Abstract

Intrathecal serotherapy appears to be effective in the treatment of tetanus, and it has been claimed that human immune globulins are innocuous. In the 4 cases reported here reversible paraplegia developed a few hours after intrathecal injection of 1500 to 2000 UI of human immune globulins prepared by the French Blood Transfusion Centre. We believe that paraplegia was related to the high doses administered. The fact that intrathecal serotherapy is normally used in severely ill patients whose impaired consciousness precludes motricity and sensitivity testing may explain why this complication has not previously been reported. The need for high doses of intrathecal immune globulins is discussed. It has recently been suggested that high doses are superior to low doses. We consider that this form of treatment is justified, even in the least severe forms of tetanus, but we feel that doses higher than 1000 IU are not without danger.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207524

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

Review 1.  Maternal and neonatal tetanus.

Authors:  C Louise Thwaites; Nicholas J Beeching; Charles R Newton
Journal:  Lancet       Date:  2014-08-19       Impact factor: 79.321

2.  Management of tetanus: a review of 18 cases.

Authors:  K O Sun; Y W Chan; R T Cheung; P C So; Y L Yu; P C Li
Journal:  J R Soc Med       Date:  1994-03       Impact factor: 18.000

Review 3.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

4.  A Pilot Study to Assess Safety and Feasibility of Intrathecal Immunoglobulin for the Treatment of Adults with Tetanus.

Authors:  Huynh Thi Loan; Lam Minh Yen; Evelyne Kestelyn; Nguyen Van Hao; Nguyen Thi Hoang Mai; Duong Bich Thuy; Ha Thi Hai Duong; Nguyen Thi Phuong Dung; Nguyen Hoan Phu; Pham Thi Lieu; Tran Tan Thanh; Ronald Geskus; H Rogier van Doorn; Le Van Tan; Duncan Wyncoll; Nicholas P J Day; Tran Tinh Hien; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  Am J Trop Med Hyg       Date:  2018-06-14       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.